U.S. Medical Foods Market was valued at US$ 10,991.5 million in 2019, and is expected to exhibit a CAGR of 17.1% over the forecast period (2019-2027), as highlighted in a new report published by.
Increasing focus of key players on strengthening their market position by collaborating with other producers for development and commercialization of efficient medical food products is driving growth of the market. For instance, in November 2018, Entrinsic Health Solutions (EHS), an innovative health sciences company entered into a partnership agreement with Nestlé Health Science, a global innovative leader pioneering premium-quality, science-based nutritional health solutions for commercialization of Enterade is an electrolyte beverage containing amino acids and electrolyte designed for patients with gastrointestinal discomfort. Moreover, in September 2020, Dutch Medical Food made its timely entry to the scene amid heightened demand for medical foods and a consumer shift toward adopting healthy alternatives, caused by the increasing cost of medical services. Furthermore, in June 2021, Otsuka Pharmaceutical Factory, Inc. has renewed its concentrated liquid diet products “Hine E-Gel®” and “Hine E-Gel® LC,” and release new products with changed names (product names) and some compositions, “HINEX® E-Gel” and “HINEX® E-gel LC globally under the “HINEX” brand-. The company has worked to develop products focusing on nutritional foods that can be taken orally by patients, making use of its ability to develop clinical nutritional products, mainly IV products.
Click Here to Get a Sample Copy (Exclusive Offer: Up to 30% Discount for A Limited Time) @ https://www.coherentmarketinsights.com/insight/request-sample/3215
Key players are focusing on strategic collaborations, in order to develop therapeutic agents and biomarkers for gastrointestinal diseases. For instance in January 2016, Enterome SA entered into a collaborative research agreement with Janssen Biotech, Inc. for discovery of novel targets and therapeutic agents for Crohn’s disease. Moreover, in January 2016, Takeda Pharmaceutical Company Ltd. and Enterome SA entered into a strategic drug discovery collaboration to research and develop potential microbiome-based new therapeutic agents for gastrointestinal disorders such as inflammatory bowel diseases.
Key Takeaways of the U.S. Medical Foods Market:
- The U.S. medical foods market is expected to exhibit a CAGR of 17.1% over the forecast period, owing to increasing awareness about medical foods in the U.S. and rising risks of gastrointestinal disease such as Cohn’s diseases or ulcerative colitis in the U.S. For instance, according to the Crohn’s & Colitis Foundation of America 2017 report, around 1.4 million people were affected from inflammatory bowel disease, of which 600,000 had Crohn’s disease or ulcerative colitis in the U.S.
- Among food type, probiotic segment held a largest market share in 2018 owing to rising demand for medical foods and growing presence of market players in U.S., is expected to propel growth of the probiotic market in the U.S. medical foods market over the forecast period.
- Among disease indication, irritable bowel syndrome (IBS) segment held a higher market share in 2018 owing to growing patient pool suffering from IBS in the U.S. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD) 2016, in the U.S., around 2.4 million and 3.5 million people visited hospitals and clinics, for the treatment of IBS.
- Companies operating in the U.S. medical foods market include Enterome SA, Yakult Honsha Co., Ltd., Abbott, ExeGi Pharma, LLC, VSL Pharmaceuticals, Inc., Entera Health, Inc., Meiji Holdings Co., Ltd., Danone, and Nestlé S.A.
Grab the Offer Mentioned Above Global Outlook and Forecast 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/3215
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Food Type
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Recent Product Launch
- PEST Analysis
- Epidemiology
- Major Brand Analysis
- Market Dynamics
- S. Medical Foods Market, By Food Type, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Prebiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Probiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Probiotic Foods
- Probiotic Supplements
- Food Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- S. Medical Foods Market, By Disease Indication, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Inflammatory Bowel Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Ulcerative Colitis
- Cohn’s Disease
- Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- S. Medical Foods Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Channel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/us-medical-foods-market-2611
About Coherent Market Insights:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837